The Latest Headlines at American Banking and Market News
Cellebrite DI Ltd. (NASDAQ:CLBT) Given Average Rating of “Buy” by Analysts
Shares of Cellebrite DI Ltd. (NASDAQ:CLBT – Get Free Report) have earned an average recommendation of “Buy” from the six research firms that are currently covering the firm, Marketbeat Ratings reports. Six investment... More of this article »
Spyre Therapeutics (NASDAQ:SYRE) and NexImmune (NASDAQ:NEXI) Head to Head Contrast
NexImmune (NASDAQ:NEXI – Get Free Report) and Spyre Therapeutics (NASDAQ:SYRE – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength... More of this article »
Alight, Inc. (NYSE:ALIT) Receives Average Rating of “Buy” from Analysts
Shares of Alight, Inc. (NYSE:ALIT – Get Free Report) have been given a consensus recommendation of “Buy” by the seven research firms that are currently covering the firm, MarketBeat.com reports. Seven analysts have... More of this article »
Comparing Clearwater Paper (NYSE:CLW) & Glatfelter (NYSE:GLT)
Clearwater Paper (NYSE:CLW – Get Free Report) and Glatfelter (NYSE:GLT – Get Free Report) are both small-cap basic materials companies, but which is the superior business? We will compare the two businesses based on the... More of this article »
Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Receives Average Rating of “Hold” from Analysts
Shares of Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Free Report) have earned a consensus recommendation of “Hold” from the three brokerages that are covering the company, MarketBeat Ratings reports. Three investment... More of this article »
SPS Commerce, Inc. (NASDAQ:SPSC) Given Consensus Rating of “Moderate Buy” by Brokerages
SPS Commerce, Inc. (NASDAQ:SPSC – Get Free Report) has earned an average recommendation of “Moderate Buy” from the seven brokerages that are presently covering the firm, Marketbeat Ratings reports. Two investment... More of this article »
Nerdy, Inc. (NYSE:NRDY) Receives Average Rating of “Moderate Buy” from Brokerages
Shares of Nerdy, Inc. (NYSE:NRDY – Get Free Report) have received an average rating of “Moderate Buy” from the six ratings firms that are currently covering the stock, Marketbeat.com reports. One investment analyst... More of this article »
Loblaw Companies Limited (TSE:L) Given Average Rating of “Moderate Buy” by Brokerages
Shares of Loblaw Companies Limited (TSE:L – Get Free Report) have earned an average rating of “Moderate Buy” from the six brokerages that are covering the stock, Marketbeat Ratings reports. Two research analysts... More of this article »
GSK plc (NYSE:GSK) Receives Average Recommendation of “Hold” from Brokerages
GSK plc (NYSE:GSK – Get Free Report) has been assigned a consensus recommendation of “Hold” from the five research firms that are currently covering the firm, MarketBeat Ratings reports. One investment analyst has... More of this article »
Manhattan Associates, Inc. (NASDAQ:MANH) Given Consensus Recommendation of “Moderate Buy” by Brokerages
Shares of Manhattan Associates, Inc. (NASDAQ:MANH – Get Free Report) have been given a consensus rating of “Moderate Buy” by the seven research firms that are presently covering the stock, MarketBeat reports. Three... More of this article »
Inari Medical, Inc. (NASDAQ:NARI) Receives Average Recommendation of “Moderate Buy” from Analysts
Shares of Inari Medical, Inc. (NASDAQ:NARI – Get Free Report) have received a consensus rating of “Moderate Buy” from the seven ratings firms that are presently covering the firm, MarketBeat reports. Two equities... More of this article »
Viking Therapeutics, Inc. (NASDAQ:VKTX) Given Average Rating of “Buy” by Brokerages
Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) have received an average recommendation of “Buy” from the ten research firms that are covering the company, MarketBeat.com reports. Ten equities... More of this article »
Valvoline Inc. (NYSE:VVV) Receives Average Recommendation of “Moderate Buy” from Brokerages
Valvoline Inc. (NYSE:VVV – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the nine ratings firms that are currently covering the company, Marketbeat.com reports. Four analysts have... More of this article »